![Jean-Gabriel Judde](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Jean-Gabriel Judde
Founder at XenTech SAS
Active connections
Name | Gender | Age | Linked companies | Collaboration |
---|---|---|---|---|
Pascal Leuraud | M | - |
XenTech SAS
![]() XenTech SAS Miscellaneous Commercial ServicesCommercial Services XenTech SAS operates as a biotech and clinical research company that specializes in preclinical evaluation of cancer drug efficacy and the identification of biomarkers and therapeutic targets. The firm also engages in therapeutic development in oncology through translational platform and developing clinically relevant tumor models. The company was founded by Jean-Gabriel Judde and Pascal Leuraud in 2006 and is headquartered in Evry, France. | 18 years |
Connections Chart
Multi-company connection
Former connections
Name | Gender | Age | Linked companies | Collaboration |
---|---|---|---|---|
Arnaud Beurdeley | M | - |
XenTech SAS
![]() XenTech SAS Miscellaneous Commercial ServicesCommercial Services XenTech SAS operates as a biotech and clinical research company that specializes in preclinical evaluation of cancer drug efficacy and the identification of biomarkers and therapeutic targets. The firm also engages in therapeutic development in oncology through translational platform and developing clinically relevant tumor models. The company was founded by Jean-Gabriel Judde and Pascal Leuraud in 2006 and is headquartered in Evry, France. | - |
Marie-Emmanuelle Legrier | M | - |
XenTech SAS
![]() XenTech SAS Miscellaneous Commercial ServicesCommercial Services XenTech SAS operates as a biotech and clinical research company that specializes in preclinical evaluation of cancer drug efficacy and the identification of biomarkers and therapeutic targets. The firm also engages in therapeutic development in oncology through translational platform and developing clinically relevant tumor models. The company was founded by Jean-Gabriel Judde and Pascal Leuraud in 2006 and is headquartered in Evry, France. | - |
Bertrand Coulomb | M | - |
XenTech SAS
![]() XenTech SAS Miscellaneous Commercial ServicesCommercial Services XenTech SAS operates as a biotech and clinical research company that specializes in preclinical evaluation of cancer drug efficacy and the identification of biomarkers and therapeutic targets. The firm also engages in therapeutic development in oncology through translational platform and developing clinically relevant tumor models. The company was founded by Jean-Gabriel Judde and Pascal Leuraud in 2006 and is headquartered in Evry, France. | - |
Jean-Marc Husson | M | - |
Université Paris Diderot-Paris 7
| 3 years |
Delphine Nicolle | M | - |
XenTech SAS
![]() XenTech SAS Miscellaneous Commercial ServicesCommercial Services XenTech SAS operates as a biotech and clinical research company that specializes in preclinical evaluation of cancer drug efficacy and the identification of biomarkers and therapeutic targets. The firm also engages in therapeutic development in oncology through translational platform and developing clinically relevant tumor models. The company was founded by Jean-Gabriel Judde and Pascal Leuraud in 2006 and is headquartered in Evry, France. | - |
Ludovic Bourre | M | - |
XenTech SAS
![]() XenTech SAS Miscellaneous Commercial ServicesCommercial Services XenTech SAS operates as a biotech and clinical research company that specializes in preclinical evaluation of cancer drug efficacy and the identification of biomarkers and therapeutic targets. The firm also engages in therapeutic development in oncology through translational platform and developing clinically relevant tumor models. The company was founded by Jean-Gabriel Judde and Pascal Leuraud in 2006 and is headquartered in Evry, France. | - |
Sabrina Serpillon | M | - |
XenTech SAS
![]() XenTech SAS Miscellaneous Commercial ServicesCommercial Services XenTech SAS operates as a biotech and clinical research company that specializes in preclinical evaluation of cancer drug efficacy and the identification of biomarkers and therapeutic targets. The firm also engages in therapeutic development in oncology through translational platform and developing clinically relevant tumor models. The company was founded by Jean-Gabriel Judde and Pascal Leuraud in 2006 and is headquartered in Evry, France. | - |
Paola Bazzacco | M | - |
XenTech SAS
![]() XenTech SAS Miscellaneous Commercial ServicesCommercial Services XenTech SAS operates as a biotech and clinical research company that specializes in preclinical evaluation of cancer drug efficacy and the identification of biomarkers and therapeutic targets. The firm also engages in therapeutic development in oncology through translational platform and developing clinically relevant tumor models. The company was founded by Jean-Gabriel Judde and Pascal Leuraud in 2006 and is headquartered in Evry, France. | - |
Jerome Cheng | M | 70 |
Université Paris Diderot-Paris 7
| 4 years |
Antoine Petit | M | 64 |
Université Paris Diderot-Paris 7
| 3 years |
Statistics
Country | Connections | % of total |
---|---|---|
France | 11 | 100.00% |
Age of Connections
Active
Past
Male
Female
Members of the board
Executives
Origin of connections
- Stock Market
- Insiders
- Jean-Gabriel Judde
- Personal Network